Hearing Rehabilitation with Cochlear Implants after CyberKnife Radiosurgery of Vestibular Schwannoma: A Report Based on Four Clinical Cases

被引:3
作者
Haeussler, Sophia M. [1 ,2 ,3 ]
Szczepek, Agnieszka J. [2 ,3 ,4 ]
Graebel, Stefan [1 ,2 ,3 ]
Senger, Carolin [2 ,3 ,5 ]
Loebel, Franziska [2 ,3 ,5 ]
Kufeld, Markus [6 ]
Olze, Heidi [1 ,2 ,3 ,4 ]
机构
[1] Charite Univ Med Berlin, Dept Otorhinolaryngol Head & Neck Surg, Campus Virchow Klinikum, D-13353 Berlin, Germany
[2] Free Univ Berlin, D-13353 Berlin, Germany
[3] Humboldt Univ, D-13353 Berlin, Germany
[4] Charite Univ Med Berlin, Dept Otorhinolaryngol Head & Neck Surg, Campus Charite Mitte, D-10117 Berlin, Germany
[5] Charite Univ Med Berlin, Dept Radiat Oncol, Charite CyberKnife Ctr, D-13353 Berlin, Germany
[6] European CyberKnife Ctr Munchen Grosshadern, D-81377 Munich, Germany
关键词
cochlear implant; CyberKnife; radiosurgery; vestibular schwannoma; STEREOTACTIC RADIOSURGERY; INNER-EAR; NEUROFIBROMATOSIS TYPE-2; RADIATION; HISTOPATHOLOGY; OUTCOMES; SURGERY; ORIGIN;
D O I
10.3390/brainsci11121646
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Severe sensorineural hearing loss can be a symptom of the benign tumor vestibular schwannoma (VS). The treatment of VS with non-invasive stereotactic radiosurgery (SRS) offers a high local tumor control rate and an innovative possibility of sequential hearing rehabilitation with cochlear implantation. This study evaluated the feasibility, complications, and auditory outcomes of such a therapeutic approach. Three males and one female (mean age 65.3 +/- 9.4 years) scheduled for cochlear implantation and diagnosed with sporadic VS classified as T1 or T2 (according to Samii) were enrolled in this study. All patients had progressive hearing loss qualifying them for cochlear implantation. First, the tumor was treated using CyberKnife SRS. Next, sequential auditory rehabilitation with a cochlear implant (CI) was performed. Clinical outcomes and surgical feasibility were analyzed, and audiological results were evaluated using pure tone audiometry and speech recognition tests. All patients exhibited open-set speech understanding. The mean word recognition score (at 65 dB SPL, Freiburg Monosyllabic Test, FMT) improved after cochlear implantation in all four patients from 5.0 +/- 10% (with hearing aid) preoperatively to 60.0 +/- 22.7% six months postoperatively. Our results suggest that in patients with profound hearing loss caused by sporadic vestibular schwannoma, the tumor removal with SRS followed by cochlear implantation is an effective method of auditory rehabilitation.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma
    Patel, Kunal S.
    Ng, Edwin
    Kaur, Taranjit
    Miao, Tyler
    Kaprealian, Tania
    Lee, Percy
    Pouratian, Nader
    Selch, Michael T.
    De Salles, Antonio A. F.
    Gopen, Quinton
    Tenn, Stephen
    Yang, Isaac
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (02) : 329 - 337
  • [42] Prognostic factors of hearing preservation after gamma knife radiosurgery for vestibular schwannoma
    Kim, Chang-Hyun
    Chung, Kyu Whan
    Kong, Doo-Sik
    Nam, Do-Hyun
    Park, Kwan
    Kim, Jong-Hyun
    Hong, Sung Hwa
    Cho, Yang-Sun
    Chung, Won-Ho
    Lee, Jung-Il
    JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (02) : 214 - 218
  • [43] Long-term prognosis of preserved useful hearing after surgery in patients with vestibular schwannoma: a study of 91 cases
    Ichimasu, Norio
    Kohno, Michihiro
    Nakajima, Nobuyuki
    Matsushima, Ken
    Tanaka, Yujiro
    Tsukahara, Kiyoaki
    Inagaki, Taro
    Yoshino, Masanori
    Nagata, Osamu
    ACTA NEUROCHIRURGICA, 2020, 162 (11) : 2619 - 2628
  • [44] Hearing restoration with auditory brainstem implants after radiosurgery for neurofibromatosis Type 2 - Report of three cases
    Kalamarides, M
    Grayeli, AB
    Bouccara, D
    Ambert, E
    Sollmann, WP
    Sterkers, O
    Rey, A
    JOURNAL OF NEUROSURGERY, 2001, 95 (06) : 1028 - 1033
  • [45] Predictors of Hearing Loss After Gamma Knife Radiosurgery for Vestibular Schwannomas: Age, Cochlear Dose, and Tumor Coverage
    Brown, Melandee
    Ruckenstein, Michael
    Bigelow, Douglas
    Judy, Kevin
    Wilson, Vasthi
    Alonso-Basanta, Michelle
    Lee, John Y. K.
    NEUROSURGERY, 2011, 69 (03) : 605 - 613
  • [46] The Effect of Cochlear Dose on Hearing Preservation After Low-Dose Stereotactic Radiosurgery for Vestibular Schwannomas: A Review
    Govindaraj, Ramkumar
    Khong, Jeremy
    Byrne, Adam
    Zacest, Andrew
    Roos, Daniel
    ADVANCES IN RADIATION ONCOLOGY, 2022, 7 (06)
  • [47] Vestibular Schwannoma: The Evolution of Hearing and Tumor Size in Natural Course and after Treatment by LINAC Stereotactic Radiosurgery
    Ikonomidis, Christos
    Pica, Alessia
    Bloch, Jocelyne
    Maire, Raphael
    AUDIOLOGY AND NEURO-OTOLOGY, 2015, 20 (06) : 406 - 415
  • [48] Impact of cochlear modiolus dose on hearing preservation following stereotactic radiosurgery for non-vestibular schwannoma neoplasms of the lateral skull base: a cohort study
    Carlstrom, Lucas P.
    Jacob, Jeffrey T.
    Graffeo, Christopher S.
    Perry, Avital
    Oldenburg, Michael S.
    Foote, Robert L.
    Pollock, Bruce E.
    Driscoll, Colin L.
    Carlson, Matthew L.
    Link, Michael J.
    JOURNAL OF NEUROSURGERY, 2020, 133 (03) : 736 - 741
  • [49] Long-term hearing outcomes following stereotactic radiosurgery for vestibular schwannoma: patterns of hearing loss and variables influencing audiometric decline Clinical article
    Carlson, Matthew L.
    Jacob, Jeffrey T.
    Pollock, Bruce E.
    Neff, Brian A.
    Tombers, Nicole M.
    Driscoll, Colin L. W.
    Link, Michael J.
    JOURNAL OF NEUROSURGERY, 2013, 118 (03) : 579 - 587
  • [50] Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level
    van Linge, A.
    van Os, R.
    Hoekstra, N.
    Heijmen, B.
    Stienstra, L.
    Dallenga, A.
    Wolbers, J.
    Romero, A. Mendez
    RADIATION ONCOLOGY, 2018, 13